Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayasu Okochi

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|April 19, 2003
[The amyloid beta protein generating mechanism simultaneously generates several other peptides in Alzheimer disease--discovery of new notch-beta peptide and the possibility of its use as a marker for the diagnosis of Alzheimer disease]Masayasu Okochi, Masatoshi Takeda
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2012
[Behavioral and psychological symptoms of dementia]Masayasu Okochi, Masatoshi Takeda
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 12, 2004
[Familial Alzheimer's disease by beta-amyloid protein precursor (beta APP) mutations]Masayasu Okochi, Masatoshi Takeda
Neuro-Degenerative Diseases|February 18, 2010
Analysis of APL1beta28, a surrogate marker for Alzheimer Abeta42, indicates altered precision of gamma-cleavage in the brains of Alzheimer disease patientsMasayasu Okochi, Shinji Tagami, Masatoshi Takeda
Psychiatry and Clinical Neurosciences|August 20, 2011
New drugs for Alzheimer's disease in JapanMasatoshi Takeda, Toshihisa Tanaka, Masayasu Okochi
Brain and Nerve = Shinkei Kenkyu No Shinpo|July 26, 2017
[Cerebrospinal Fluid and Blood Biomarkers in Alzheimer's Disease]Kanta Yanagida, Shinji Tagami, Masayasu Okochi
Cell Stress|June 22, 2019
Making the final cut: pathogenic amyloid-β peptide generation by γ-secretaseHarald Steiner, Akio Fukumori, Shinji Tagami, et al.
Psychiatry and Clinical Neurosciences|January 19, 2012
Non-pharmacological intervention for dementia patientsMasatoshi Takeda, Toshihisa Tanaka, Masayasu Okochi, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|December 26, 2008
[Amyloid-beta 42 generating process may have a biological role in regulation of Notch signaling intensity]Shinji Tagami, Masayasu Okochi, Akio Fukumori, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|September 23, 2010
[Surrogate marker for ABeta42]Masayasu Okochi, Shinji Tagami, Kanta Yanagida, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|April 19, 2003
[The amyloid beta protein generating mechanism simultaneously generates several other peptides in Alzheimer disease--discovery of new notch-beta peptide and the possibility of its use as a marker for the diagnosis of Alzheimer disease]Masayasu Okochi, Masatoshi Takeda
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2012
[Behavioral and psychological symptoms of dementia]Masayasu Okochi, Masatoshi Takeda
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 12, 2004
[Familial Alzheimer's disease by beta-amyloid protein precursor (beta APP) mutations]Masayasu Okochi, Masatoshi Takeda
Neuro-Degenerative Diseases|February 18, 2010
Analysis of APL1beta28, a surrogate marker for Alzheimer Abeta42, indicates altered precision of gamma-cleavage in the brains of Alzheimer disease patientsMasayasu Okochi, Shinji Tagami, Masatoshi Takeda
Psychiatry and Clinical Neurosciences|August 20, 2011
New drugs for Alzheimer's disease in JapanMasatoshi Takeda, Toshihisa Tanaka, Masayasu Okochi
Brain and Nerve = Shinkei Kenkyu No Shinpo|July 26, 2017
[Cerebrospinal Fluid and Blood Biomarkers in Alzheimer's Disease]Kanta Yanagida, Shinji Tagami, Masayasu Okochi
Cell Stress|June 22, 2019
Making the final cut: pathogenic amyloid-β peptide generation by γ-secretaseHarald Steiner, Akio Fukumori, Shinji Tagami, et al.
Psychiatry and Clinical Neurosciences|January 19, 2012
Non-pharmacological intervention for dementia patientsMasatoshi Takeda, Toshihisa Tanaka, Masayasu Okochi, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|December 26, 2008
[Amyloid-beta 42 generating process may have a biological role in regulation of Notch signaling intensity]Shinji Tagami, Masayasu Okochi, Akio Fukumori, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|September 23, 2010
[Surrogate marker for ABeta42]Masayasu Okochi, Shinji Tagami, Kanta Yanagida, et al.
Pageof 7